A syndrome of apparent mineralocorticoid excess associated with a deficiency of 11β-hydroxysteroid dehydrogenase;Síndrome de exceso aparente de mineralocorticoides por déficit de 11 β hidroxiesteroide deshidrogenasa. Estudios clínicos y genéticos en una familia chilena afectada seguida por 19 años

Revista Medica de Chile

Volumn 128, Issue 1, 2000, Pages 17-26

  Rodríguez P, José Adolfo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Hypertension; Mineralocorticoids; Oxidoreductases

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; AMINOGLUTETHIMIDE; CORTISONE; DEXAMETHASONE; ENZYME INHIBITOR; HSD11B1 PROTEIN, HUMAN; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; CHILD; FEMALE; FOLLOW UP; GENETICS; HUMAN; HYPERTENSION; HYPOKALEMIA; INFANT; MALE; METABOLISM; MUTATION; NEWBORN; PRESCHOOL CHILD; SYNDROME;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADOLESCENT; AMINOGLUTETHIMIDE; BLOOD PRESSURE; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CORTISONE; DEXAMETHASONE; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; HYPOKALEMIA; INFANT; INFANT, NEWBORN; MALE; MINERALOCORTICOIDS; MUTATION; SYNDROME;

EID: 0033648999     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. AARSKOG D, STOA KF, THORSEN T, WEFRING KW. Hypertension and hypokalemic alkalosis associated with underproduction of aldosterone. Pediatrics 1967; 39: 884.
2. ROSS EJ. Hypertension and hypokalemia associated with hypoaldosteronism. Proc R Soc Med 1959; 52: 1086.
3. MILORA RA, VAGNUCCI A, GOODMAN AD. A syndrome resembling primary aldosteronism but without mineralocorticoid excess. Clin Res 1967; 15: 482.
4. WERDER EA, ZACHMANN M, VOLLMAN JA, VEYRAT R, PRADER A. Unusual steroid excretion in a child with apparent mineralocorticoid hypertension. Res Steroids 1974; 6: 385-9.
5. NEW MI, LEVINE LS, BIGLIERI EG, PAREIRA J, ULICK S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 1997; 44: 924-33.
6. ULICK S, LEVINE L, GUNCZLER P, ZANCONATO G, RAMÍREZ LG, RAUH W, RÖSLER A, BRADLOW HL, NEW MI. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979; 49: 757-64.
7. SHACKLETON CH, RODRÍGUEZ JA, ARTEAGA E, LÓPEZ JM, WINTER JS. Congenital 11 beta hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin Endocrinol (Oxf) 1985; 22: 701-12.
8. MUNE T, ROGERSON FM, NIKKILÄ H, AGARWAL AK, WHITE PC. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genetics 1995; 10: 394-9.
9. MATTINGLY DA. A simple fluorometric method for the estimation of free 11-hydroxysteroids in human plasma. J Clin Pathol 1962; 15: 374-9.
10. HABER E, KOERNER T, PAGE L, KLIMAN B, PURNODE A. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 1969; 29: 1349.
11. BROWN RD, SWANDER A, MCKENZIE JK. Urine aldosterone radioimmunoassay: validation of a method without chromatography. J Clin Endocrinol Metab 1976; 42: 894-930.
12. BIGLIERI EG, WACHJENGERG BL, MALERBI DA, OKADA H, LEME CE, KATER CE. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1981; 53: 964-9.
13. SHIMKETS RA, WARNOCK DG, BOSITIS CM, NELSON-WILLIAMS C, HANSSON JH, SCHAMDELAN M, GILL JR JR, ULICK S, FINDLING JW, CANESSA CM, ROSSIER BC, LIFTON RP. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 1994; 79: 407-14.
14. HANSSON JH, NELSON-WILLIAMS C, SUZUKI H, SCHILD L, SHIMKETS R, LU Y, CANESSA C, IWASAKI T, ROSSIER B, LIFTON RP. Hypertension caused by a truncated epithelial sodium channel gamma subunit: ganetic heterogeneity of Liddle's syndrome. Nat Genet 1995; 11: 76-82.
15. ODERFIELD SE, LEBINE LS, CAREY RM, GREIG F, ULICK S, NEW MI. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1983; 56: 332-9.
16. AMELUNG D, HUEBENER HJ, ROKA L, MEYERHEIM G. Conversion of cortisone to compound F. J Clin Endocrinol Metab 1953; 13: 1125.
17. HUEBENER HJ, FUKUSHIMA DK, GALLAGHER TF. Substrate specificity of enzymes reducing the 11-and 20-keto groups of steroids. J Biol Chem 1956; 220: 499-511.
18. EDWARDS CR, STEWART PM, BURT D, BRETT L, MCINTYRE MA, SUTANTO WS, DE KLOET ER, MONDER C. Localization of 11β-hydroxysteroid dehydrogenase, tissue-specific protector of the mineralocorticoid receptor. Lancet 1998; 2: 986-9.
19. FUNDER JW, PEARCE PT, SMITH R, SMITH AI. Mine-ralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583-5.
20. CARD WI, MITCHELL W, STRONG JA, TAYLOR NR, TOMPSETT SL, WILSON JMG. Effects of liquorice and its derivatives on salt and water metabolism. Lancet 1953; 1: 663-8.
21. ROGOFF D, SMOLENICKA Z, BERGADÁ I, VALLEJO G, BARONTINI M, HEINRICH JJ, FERRARI P. The codon 213 of the 11 β-hydroxysteroid dehydrogenase type 2 gene is a hot spot for mutations in apparent mineralocorticoid excess. J Clin Endocrinol Metab 1998; 83: 4391-3.
22. WHITE PC, MUNE T, AGARWAL AK. 11 β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997; 18: 135-56.